Chernobyl: chasing a ‘catching’ cancer

2022-11-28T23:22:46+00:007 December 2018|

Sanger researcher Alex Cagan travelled to Chernobyl’s nuclear exclusion zone for samples of cancer. But he isn’t investigating the effects of the reactor disaster; his quarry has a more ancient source: the immortal cells of an 8,000 year-old animal that are still being passed from dog to dog

Turning DREAM into reality

2016-01-21T15:15:27+00:0021 January 2016|

21.01.16 David Wedge reports the launch of a new DREAM Challenge that aims to identify the different cells that make up a cancer

Following cancer’s journey

2015-04-01T18:30:28+01:001 April 2015|

01.04.15 How do tumours move between organs? Are they competing when they spread or do they work cooperatively? David Wedge looks for answers in a new prostate cancer study

Is the playing field level in prostate cancer?

2015-04-01T11:13:12+01:001 April 2015|

01.04.15 Between competing prostate tumours there are often areas of normal tissue. David Wedge asks whether these healthy cells are actually creating a field effect that facilitates cancer’s spread

How can we see our immune system?

2015-01-20T12:31:56+00:0020 January 2015|

19.01.15 By sequencing individual immune cells, scientists can now look at the way our bodies respond to infection and disease. Rachael Bashford-Rogers explains what this new viewpoint could show us

A molecular archaeologist’s toolkit

2015-01-14T10:26:46+00:0014 January 2015|

14.01.15 Like archaeologists, cancer researchers piece together the shards of past catastrophe. However, as Moritz Gerstung explains, algorithms, not brushes, are the tools of the trade

Targeting skin cancers

2014-11-26T10:46:52+00:0026 November 2014|

26.11.14 Many melanomas don’t respond to existing drugs and most eventually become resistant to treatment. Marco Ranzani explains how researchers are searching for new therapies